VERTEX PHARMACEUTICALS INC (VRTX)

US92532F1003 - Common Stock

397.27  +0.63 (+0.16%)

After market: 394.85 -2.42 (-0.61%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
7.574B
22.06%
8.931B
17.91%
9.869B
10.51%
11.107B
12.54%
12.053B
8.52%
13.24B
9.85%
14.254B
7.66%
15.801B
10.85%
17.33B
9.68%
19.177B
10.66%
20.543B
7.12%
EBITDA
YoY % growth
2.908B
-1.96%
4.469B
53.69%
4.54B
1.60%
1.32B
-70.93%
5.733B
334.32%
6.485B
13.12%
7.217B
11.29%
8.186B
13.43%
9.195B
12.33%
10.1B
9.84%
10.924B
8.16%
EBIT
YoY % growth
2.782B
-2.60%
4.32B
55.29%
4.359B
0.90%
661.68M
-84.82%
5.564B
740.89%
6.317B
13.53%
7.154B
13.25%
8.242B
15.21%
9.055B
9.86%
10.01B
10.55%
10.632B
6.21%
Operating Margin
36.73%48.38%44.17%5.96%46.16%47.71%50.19%52.16%52.25%52.20%51.75%
EPS
YoY % growth
13.02
26.16%
14.89
14.36%
15.22
2.22%
0.60
-96.09%
19.19
3,121.81%
20.84
8.61%
23.35
12.03%
26.69
14.31%
29.77
11.52%
33.44
12.32%
36.77
9.98%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
4.17
-0.62%
4.55
-4.49%
4.76
137.14%
4.93
12.67%
5.23
25.27%
Revenue
Q2Q % growth
2.841B
12.84%
2.854B
6.07%
2.893B
9.35%
2.994B
8.01%
3.226B
13.55%
EBITDA
Q2Q % growth
1.235B
3.99%
N/AN/AN/AN/A
EBIT
Q2Q % growth
1.197B
18.95%
1.233B
1.37%
1.28B
36.99%
1.346B
18.98%
1.479B
23.56%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
4.38
7.35%
4.220.163.69%
Q2 2024
Q2Q % growth
-12.83
-429.82%
3.00-15.83-527.57%
Q1 2024
Q2Q % growth
4.76
56.07%
4.140.6214.85%
Q4 2023
Q2Q % growth
4.20
11.70%
4.180.020.36%
Q3 2023
Q2Q % growth
4.08
1.75%
4.050.030.66%
Q2 2023
Q2Q % growth
3.89
8.06%
3.96-0.07-1.75%
Q1 2023
Q2Q % growth
3.05
-13.35%
3.06-0.01-0.21%
Q4 2022
Q2Q % growth
3.76
11.57%
3.580.184.95%
Q3 2022
Q2Q % growth
4.01
12.64%
3.720.297.89%
Q2 2022
Q2Q % growth
3.60
15.76%
3.550.051.44%
Q1 2022
Q2Q % growth
3.52
18.12%
3.56-0.04-1.18%
Q4 2021
Q2Q % growth
3.37
34.26%
3.370.000.13%
Q3 2021
Q2Q % growth
3.56
34.85%
3.140.4213.27%
Q2 2021
Q2Q % growth
3.11
19.16%
2.560.5521.59%
Q1 2021
Q2Q % growth
2.98
16.41%
2.740.248.66%
Q4 2020
Q2Q % growth
2.51
47.65%
2.64-0.13-5.00%
Q3 2020
Q2Q % growth
2.64
114.63%
2.390.2510.49%
Q2 2020
Q2Q % growth
2.61
107.14%
2.120.4923.38%
Q1 2020
Q2Q % growth
2.56
124.56%
1.880.6836.03%
Q4 2019
Q2Q % growth
1.70
30.77%
1.230.4738.03%
Q3 2019
Q2Q % growth
1.23
12.84%
1.170.064.95%
Q2 2019
Q2Q % growth
1.26
34.04%
1.090.1715.76%
Q1 2019
Q2Q % growth
1.14
50.00%
0.990.1514.85%
Q4 2018
Q2Q % growth
1.30 1.080.2219.98%
Q3 2018
Q2Q % growth
1.09 1.040.054.88%
Q2 2018
Q2Q % growth
0.94 0.760.1823.38%
Q1 2018
Q2Q % growth
0.76 0.640.1218.55%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
2.772B
11.61%
2.778B-6.1M-0.22%
Q2 2024
Q2Q % growth
2.646B
6.11%
2.715B-69.4M-2.56%
Q1 2024
Q2Q % growth
2.691B
13.30%
2.63B60.6M2.30%
Q4 2023
Q2Q % growth
2.518B
9.34%
2.564B-46.3M-1.81%
Q3 2023
Q2Q % growth
2.484B
6.39%
2.55B-66.5M-2.61%
Q2 2023
Q2Q % growth
2.493B
13.52%
2.468B25.2M1.02%
Q1 2023
Q2Q % growth
2.375B
13.22%
2.384B-9.2M-0.39%
Q4 2022
Q2Q % growth
2.303B
11.10%
2.347B-44.3M-1.89%
Q3 2022
Q2Q % growth
2.334B
17.64%
2.271B63.3M2.79%
Q2 2022
Q2Q % growth
2.196B
22.46%
2.175B21.2M0.97%
Q1 2022
Q2Q % growth
2.098B
21.64%
2.118B-20.5M-0.97%
Q4 2021
Q2Q % growth
2.073B
27.33%
2.043B29.6M1.45%
Q3 2021
Q2Q % growth
1.984B
28.99%
1.893B91.2M4.82%
Q2 2021
Q2Q % growth
1.793B
17.64%
1.752B41.4M2.36%
Q1 2021
Q2Q % growth
1.724B
13.81%
1.69B34.3M2.03%
Q4 2020
Q2Q % growth
1.628B
15.18%
1.616B11.8M0.73%
Q3 2020
Q2Q % growth
1.538B
61.96%
1.515B23.3M1.54%
Q2 2020
Q2Q % growth
1.525B
61.96%
1.413B111.5M7.89%
Q1 2020
Q2Q % growth
1.515B
76.50%
1.313B202.1M15.39%
Q4 2019
Q2Q % growth
1.413B
62.43%
1.033B380.3M36.82%
Q3 2019
Q2Q % growth
949.8M
21.07%
969.92M-20.12M-2.07%
Q2 2019
Q2Q % growth
941.3M
25.14%
903.29M38.01M4.21%
Q1 2019
Q2Q % growth
858.4M
33.96%
867.48M-9.08M-1.05%
Q4 2018
Q2Q % growth
870.1M 836.53M33.57M4.01%
Q3 2018
Q2Q % growth
784.5M 806.72M-22.22M-2.75%
Q2 2018
Q2Q % growth
752.2M 694.6M57.6M8.29%
Q1 2018
Q2Q % growth
640.8M 635.11M5.69M0.90%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.14% 1.21% 46.6% 81.58%
Revenue0% 1.83% 0.31% 1.25%